{"ORPHApacket":[{"ORPHApacketID":"67047","date":"2019-12-05 18:07:25","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"67047","Name":[{"lang":"en","label":"3-methylglutaconic aciduria type 3"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_67047","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"3-methylglutaconic aciduria"}],"ORPHA":"289902","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_289902"},{"Name":[{"lang":"en","label":"Syndromic hereditary optic neuropathy"}],"ORPHA":"441434","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_441434"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"3-methylglutaconic aciduria type III (MGA III) is an organic aciduria characterised by the association of optic atrophy and choreoathetosis with 3-methylglutaconic aciduria."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"258501","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"6","Synonym":[{"lang":"en","label":"Autosomal recessive optic atrophy plus syndrome"},{"lang":"en","label":"Autosomal recessive optic atrophy type 3"},{"lang":"en","label":"Costeff optic atrophy syndrome"},{"lang":"en","label":"Costeff syndrome"},{"lang":"en","label":"Infantile optic atrophy with chorea and spastic paraplegia"},{"lang":"en","label":"MGA3"}]}],"DisorderGeneAssociationList":[{"count":"2","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"mitochondrial contact site and cristae organizing system subunit 13"}],"Symbol":"MICOS13","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"OMIM","Reference":"616658"},{"Source":"HGNC","Reference":"33702"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]},{"Gene":[{"Name":[{"lang":"en","label":"outer mitochondrial membrane lipid metabolism regulator OPA3"}],"Symbol":"OPA3","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"8142"},{"Source":"OMIM","Reference":"606580"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"9","HPODisorderAssociation":[{"HPOId":"HP:0000505","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000505","HPOTerm":"Visual impairment","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000639","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000639","HPOTerm":"Nystagmus","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001249","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001249","HPOTerm":"Intellectual disability","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001251","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001251","HPOTerm":"Ataxia","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001260","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001260","HPOTerm":"Dysarthria","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001266","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001266","HPOTerm":"Choreoathetosis","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001288","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001288","HPOTerm":"Gait disturbance","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002313","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002313","HPOTerm":"Spastic paraparesis","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003535","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003535","HPOTerm":"3-Methylglutaconic aciduria","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}